Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Titan Machinery
TITN
$448M
| $216K | ﹤0.01% |
19,899
+12,001
| +152% | +$115K |
|
3952
CALL
Ventas
VTR
$47.3B
| $216K | ﹤0.01% |
5,900
-68,800
| -92% | -$2.27M |
|
3953
CALL
Ambarella
AMBA
$3.68B
| $215K | ﹤0.01% |
4,700
-23,300
| -83% | -$1.2M |
|
3954
PUT
Coherent
COHR
$65.4B
| $215K | ﹤0.01% |
4,558
-28,300
| -86% | -$1.12M |
|
3955
CALL
Cemex
CX
$16.3B
| $215K | ﹤0.01% |
74,600
-14,100
| -16% | -$33.1K |
|
3956
Hyster-Yale Materials Handling
HY
$662M
| $215K | ﹤0.01% |
5,572
+2,206
| +66% | +$82.2K |
|
3957
Republic Bancorp
RBCAA
$1.96B
| $215K | ﹤0.01% |
6,539
+3,318
| +103% | +$105K |
|
3958
Voyager Therapeutics
VYGR
$189M
| $215K | ﹤0.01% |
17,002
+7,984
| +89% | +$92.9K |
|
3959
CALL
Williams Companies
WMB
$87.8B
| $215K | ﹤0.01% |
11,300
-28,900
| -72% | -$538K |
|
3960
National Fuel Gas
NFG
$7.66B
| $214K | ﹤0.01% |
5,107
-210,059
| -98% | -$8.58M |
|
3961
Personalis
PSNL
$1.39B
| $214K | ﹤0.01% |
16,501
+10,266
| +165% | +$114K |
|
|
LDL
3962
DELISTED
Lydall, Inc.
LDL
| $214K | ﹤0.01% |
15,785
-1,314
| -8% | -$14.5K |
|
3963
CALL
Direxion Daily Energy Bear 2X ETF
ERY
$40.9M
| $213K | ﹤0.01% |
430
-720
| -63% | -$451K |
|
3964
CALL
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $213K | ﹤0.01% |
6,000
-16,500
| -73% | -$548K |
|
3965
MannKind Corp
MNKD
$1.25B
| $213K | ﹤0.01% |
121,467
+22,380
| +23% | +$31.3K |
|
3966
NextCure
NXTC
$22.7M
| $213K | ﹤0.01% |
828
+341
| +70% | +$130K |
|
3967
RBB Bancorp
RBB
$455M
| $213K | ﹤0.01% |
15,581
+10,199
| +190% | +$132K |
|
3968
Spyre Therapeutics
SYRE
$9.12B
| $213K | ﹤0.01% |
925
+578
| +167% | +$110K |
|
3969
First Mid Bancshares
FMBH
$1.38B
| $212K | ﹤0.01% |
8,061
+3,236
| +67% | +$81.1K |
|
3970
CALL
Jacobs Solutions
J
$16.9B
| $212K | ﹤0.01% |
3,022
-7,012
| -70% | -$473K |
|
3971
PUT
Kinross Gold
KGC
$30.4B
| $212K | ﹤0.01% |
29,300
-64,400
| -69% | -$418K |
|
|
LNW
3972
CALL
DELISTED
Light & Wonder
LNW
| $212K | ﹤0.01% |
13,700
-11,900
| -46% | -$155K |
|
|
SPWR
3973
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
| $212K | ﹤0.01% |
42,298
-64,439
| -60% | -$294K |
|
3974
CALL
Masco
MAS
$14.9B
| $211K | ﹤0.01% |
4,200
-64,900
| -94% | -$2.81M |
|
3975
Seneca Foods Class A
SENEA
$1.13B
| $211K | ﹤0.01% |
6,266
+711
| +13% | +$25K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.